Hence, while the expansion of NOD2-dependent I-NCMs is an attractive strategy, as they can migrate into metastasis throughout the body, our data suggest that their function is dependent on signaling by CCL2/CCR2, which could vary depending on tissues, tumor burden, acquisition of CCL2 mutations, and other biological factors. Here, CCL2 is linked to neoplasm.